TP53 and ovarian carcinoma: Zhao et al. observed associations between increased apoptosis by high expression of phosphorylated c-Jun N-terminal kinase (JNK) and subsequently elevated expression levels of p53 in ovarian cancer cells during treatment of platinum containing drugs [38].